Device Trial Radar · NCT02954042
Pelvital Stress Urinary Incontinence Training Device: P-SUIT
Last checked: Nov 20, 2026Latest source record: Apr 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Actual
Start
Mar 10, 2017
Primary completion
Oct 30, 2019
Study completion Oct 30, 2019
Sponsor
- Lead sponsor
- Pelvital USA, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 3, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this investigation is to compare the clinical benefits of using the Pelvital product, in comparison to a sham procedure as a noninvasive treatment for female incontinence
Conditions
- Incontinence
Interventions
Pelvital probeDevice
Pelvital probe
Placebo ProbeDevice
Placebo Probe
Primary outcomes
What the sponsor says the trial is designed to measure.
- Improvement in severity of involuntary urine lossTime frame: Baseline, 6 weeks
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
University of Minnesota Medical Center
Maple Grove, Minnesota
Metro OBGYN
Maplewood, Minnesota
University of Minnesota Medical Center
Minneapolis, Minnesota
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.